Accomplished and versatile global regulatory affairs executive with a passion for building high-performing teams and identifying creative therapeutic product development strategies. Skilled at providing strategic regulatory guidance and support for multiple product types including small molecules, monoclonal antibodies, xenotransplantation, cell therapy, medical devices, and drug/device combination products. Highly focused and milestone-driven with an acute understanding of regulatory, scientific, and corporate objectives.